AIFF Stock Catalyst: Firefly Neuroscience Advances Research on Brain Age Assessment Using BNA™ Technology

Jan 13, 2025 · 7:57pm ET

Company leverages FDA-cleared platform for new study.

Max move

+206.8%

High of day $5.80

Sparker timei

7:57pm ET

AIFF · Jan 13, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Firefly Neuroscience, Inc. (Nasdaq: AIFF) announced on January 14, 2025, the progression of its research to evaluate a patient's brain age utilizing its FDA-cleared BNA™ technology platform.

The research aims to further understand and assess brain age through the application of the BNA™ technology, which has already received clearance from the FDA.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time AIFF sparks.

Download Sniper App →

Catch the next AIFF-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →